expecting income., page-12

chil020

The May 2011 Southern Cross Equities Research on Prima's website as per below and below that is what wisdom posted from his email correspondence with MR?????


""There is the potential for near term data on CVac efficacy. The IIb trial
vaccinates patients every four weeks for 24 weeks, followed by booster
injections every eight weeks until week 48. The aim of the trial will be to
generate superior data on Progression Free Survival compared to standard of
care. We understand that PRR has included in the IIb trial protocol an ?interim
data point? in which the company can look at the data to see if the trial is
sufficiently powered. We expect that interim data, if any, could be available
within a year of first dose, that is, around July 2011;""


""re: investor presentation (wisdomofsilence)
Forum: ASX - By Stock (Back)
Code: PRR - PRIMA BIOMED LTD ( 18c | Price Chart | $180.59M | Announcements | Google PRR)
Post: 6933208
Reply to: #6932041 from Slats7 Views: 759
Posted: 12/07/11 11:55 Stock Price (at time of posting): 30.5c Sentiment: Buy Disclosure: Stock Held From: 120.145.xxx.xxx

I cant believe people are still bleating on about no metion of NASDAQ listing when its been made painfully obvious that: a)listing is IMMINENT and b)PRR have been told by the governing body not to mention it again!!!
Geez louise!!!! Get over it...

On a far brighter note, a nice juicy announcement by the Company this morning. Im inclined to agree that this has been released "just in time" to be the first thing our new investors see when they click on "announcements"....and wont they be blown away!!!

In my recent correspondence with MR he had this to say...
"The main point of the phase IIb has been the manufacturing and safety data which has already been reported. We will do interim results at American Society of Clinical Oncology (ASCO) next year June 1-5 and headline PFS data approximately next year with a date yet to be set."